MedPath

Paroxetine

Generic Name
Paroxetine
Brand Names
Paxil, Pexeva
Drug Type
Small Molecule
Chemical Formula
C19H20FNO3
CAS Number
61869-08-7
Unique Ingredient Identifier
41VRH5220H

Overview

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) drug commonly known as Paxil. It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others. It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham. A unique feature of this drug is that it is highly potent and selective in its inhibition of serotonin reuptake and has little effect on other neurotransmitters. Because of its potent inhibition of serotonin reuptake, paroxetine is more likely to cause withdrawal effects upon cessation. Paroxetine is well tolerated in most patients with a similar adverse effect profile to other members of its drug class. The controlled release formulation was designed to decrease the likelihood of nausea that is sometimes associated with paroxetine.

Background

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) drug commonly known as Paxil. It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others. It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham. A unique feature of this drug is that it is highly potent and selective in its inhibition of serotonin reuptake and has little effect on other neurotransmitters. Because of its potent inhibition of serotonin reuptake, paroxetine is more likely to cause withdrawal effects upon cessation. Paroxetine is well tolerated in most patients with a similar adverse effect profile to other members of its drug class. The controlled release formulation was designed to decrease the likelihood of nausea that is sometimes associated with paroxetine.

Indication

Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder. One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause. Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).

Associated Conditions

  • Generalized Anxiety Disorder
  • Irritable Bowel Syndrome (IBS)
  • Major Depressive Disorder (MDD)
  • Obsessive Compulsive Disorder (OCD)
  • Panic Disorder
  • Post Traumatic Stress Disorder (PTSD)
  • Premature Ejaculation
  • Premenstrual Dysphoric Disorder (PMDD)
  • Social Anxiety Disorder (SAD)
  • Vasomotor Symptoms Associated With Menopause

FDA Approved Products

Paroxetine
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:40 mg in 1 1
Approved: 2010/05/29
NDC:53808-0756
Paroxetine
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:30 mg in 1 1
Approved: 2010/05/29
NDC:53808-0752
Paroxetine
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:20 mg in 1 1
Approved: 2010/05/29
NDC:53808-0749
PAXIL CR
Manufacturer:Apotex Corp
Route:ORAL
Strength:25 mg in 1 1
Approved: 2024/01/10
NDC:60505-4378
paroxetine hydrochloride
Manufacturer:Oxford Pharmaceuticals, LLC
Route:ORAL
Strength:40 mg in 1 1
Approved: 2022/06/01
NDC:69584-674

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath